Use of mechanistic models to integrate and analyze multiple proteomic datasets.
Stites EC, Aziz M, Creamer MS, Von Hoff DD, Posner RG, Hlavacek WS.
Biophysical Journal. 2015.

Cooperation between Noncanonical Ras Network Mutations.
Stites EC, Trampont PC, Haney LB, Walk SF, Ravichandran KS.
Cell Reports. 2015.

Allosteric activation of functionally asymmetric RAF kinase dimers.
Hu J, Stites EC, Yu H, Germino EA, Meharena HS, Stork PJ, Kornev AP, Taylor SS, Shaw AS.
Cell. 2013.

Chemical kinetic mechanistic models to investigate cancer biology and impact cancer medicine.
Stites EC.
Physical Biology. 2013.

Innovations of the rule-based modeling approach
Chylek LA, Stites EC, Posner RG, Hlavacek WS.
Systems Biology. 2013.

The response of cancers to BRAF inhibition underscores the importance of cancer systems biology.
Stites EC.
Science Signaling. 2012.

Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling.
Creamer MS, Stites EC, Aziz M, Cahill JA, Tan CW, Berens ME, Han H, Bussey KJ, Von Hoff DD, Hlavacek WS, Posner RG.
BMC Systems Biology. 2012.

Mechanistic modeling to investigate signaling by oncogenic Ras mutants.
Stites EC, Ravichandran KS.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine. 2012.

Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing.
Liang WS, Craig DW, Carpten J, Borad MJ, Demeure MJ, Weiss GJ, Izatt T, Sinari S, Christoforides A, Aldrich J, Kurdoglu A, Barrett M, Phillips L, Benson H, Tembe W, Braggio E, Kiefer JA, Legendre C, Posner R, Hostetter GH, Baker A, Egan JB, Han H, Lake D, Stites EC, Ramanathan RK, Fonseca R, Stewart AK, Von Hoff D.
PloS One. 2012.

Mathematical investigation of how oncogenic ras mutants promote ras signaling.
Stites EC, Ravichandran KS.
Methods in Molecular Biology. 2012.

Modeling membrane localization: case study of a Ras signaling model.
Stites EC.
Advances in Experimental Medicine and Biology. 2010.

A systems perspective of ras signaling in cancer.
Stites EC, Ravichandran KS.
Clinical Cancer Research. 2009.

Network analysis of oncogenic Ras activation in cancer.
Stites EC, Trampont PC, Ma Z, Ravichandran KS.
Science. 2007.

Sensitivity and versatility of an adaptive system for controlling cyclic movements using functional neuromuscular stimulation.
Stites EC, Abbas JJ.
IEEE Transactions on Biomedical Engineering. 2000.


Differences in sensitivity to EGFR inhibitors could be explained by described biochemical differences between oncogenic Ras mutants
Stites EC
bioRxiv, 2014